Cargando…

Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data

BACKGROUND: Varicella, a contagious infectious disease caused by varicella zoster virus (VZV), can result in hospitalization and, occasionally, death. Varicella virus vaccine live (VVVL [VARIVAX]) was introduced in the United States in 1995. METHODS: This comprehensive review of the VVVL safety prof...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woodward, Meredith, Marko, Ann, Galea, Susan, Eagel, Barry, Straus, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685817/ https://www.ncbi.nlm.nih.gov/pubmed/31392326 http://dx.doi.org/10.1093/ofid/ofz295

Ejemplares similares

Increased Incidence of Giant Cell Arteritis After Introduction of a Live Varicella Zoster Virus Vaccine
por: Agger, William A, et al.
Publicado: (2020)

Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer
por: Boeckh, Michael J, et al.
Publicado: (2020)

Continuing Decline in Varicella Incidence After the 2-Dose Vaccination Recommendation—Connecticut, 2009–2014
por: Mullins, Jocelyn, et al.
Publicado: (2015)

Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant
por: Desjardins, Michaël, et al.
Publicado: (2021)

No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination
por: Carryn, Stephane, et al.
Publicado: (2021)

Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
por: Gershon, Anne A, et al.
Publicado: (2021)

Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)–Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women
por: Perciani, Catia T, et al.
Publicado: (2018)

14. Postmarketing Safety Experience With MenACWY-TT
por: Serra, Lidia, et al.
Publicado: (2021)

Delineating the Seasonality of Varicella and Its Association With Climate in the Tropical Country of Colombia
por: Barrero Guevara, Laura Andrea, et al.
Publicado: (2023)

Trends in Hospitalizations With Primary Varicella and Herpes Zoster During the Prevaricella and Initial Postvaricella and Herpes Zoster Vaccine Eras, Connecticut, 1994–2012
por: Humes, Elizabeth A., et al.
Publicado: (2015)

Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older
por: Pillsbury, Alexis J., et al.
Publicado: (2020)

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)
por: Rivera, Luis, et al.
Publicado: (2021)

Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine Candidate
por: Patel, Sanjay S, et al.
Publicado: (2022)

Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus
por: Heusel, Ethan H., et al.
Publicado: (2020)

Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
por: Singh, Tina, et al.
Publicado: (2022)

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US
por: Jara, Michele, et al.
Publicado: (2013)

Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)

Prevalence and Characteristics of Neuroinfectious Disease Inquiries Within the Emerging Infections Network: A 22-Year Retrospective Study
por: Matthews, Elizabeth, et al.
Publicado: (2020)

Postmarketing Safety Study Tool: A Web Based, Dynamic, and Interoperable System for Postmarketing Drug Surveillance Studies
por: Sinaci, A. Anil, et al.
Publicado: (2015)

Seropositivity, Risks, and Morbidity From Varicella-Zoster Virus Infections in an Adult PWH Cohort From 2000–2020
por: Zou, Jason, et al.
Publicado: (2022)

Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
por: Dhanda, Sandeep, et al.
Publicado: (2022)

Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
por: Day, John W., et al.
Publicado: (2021)

Correction to: Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
por: Singh, Tina, et al.
Publicado: (2022)

Eight-Year Postmarket Safety Surveillance of Delayed Complications With a Flexible Lip Filler
por: Cohen, Joel L., et al.
Publicado: (2022)

Pneumococcal Conjugate Vaccine Safety in Elderly Adults
por: Tseng, Hung Fu, et al.
Publicado: (2018)

Safety of Interchanging the Live Attenuated MAV/06 Strain and OKA Strain Varicella Vaccines in Children
por: Kang, Hyun Mi, et al.
Publicado: (2023)

1048 Pregnancy Registry for Varicella-Zoster Virus-Containing Vaccines: 18-Year Summary of Pregnancy Outcomes
por: Willis, English, et al.
Publicado: (2014)

571. A Report of the Postmarketing Spontaneous Safety Data over 24 Years for GSK’s Measles-Mumps-Rubella (MMR) Vaccine
por: Singh, Tina, et al.
Publicado: (2022)

Ten-Year Global Postmarket Safety Surveillance of Delayed Complications With a Flexible Cheek Filler
por: Cohen, Joel L., et al.
Publicado: (2022)

Postmarketing Surveillance Study of the Efficacy and Safety of Phentermine in Patients with Obesity
por: Kim, Hyun Ok, et al.
Publicado: (2013)

Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan†
por: Kurita, Tomoko, et al.
Publicado: (2014)

An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
por: Misu, Takashi, et al.
Publicado: (2018)

Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
por: Day, John W., et al.
Publicado: (2021)

Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting
por: Schotland, Peter, et al.
Publicado: (2020)

Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
por: Garafola, Svetlana, et al.
Publicado: (2023)

The safety profile of COVID-19 vaccinations in the United States
por: Singh, Amninder, et al.
Publicado: (2022)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

Varicella Vaccine
por: Duff, Patrick
Publicado: (1996)

Viral Genome Sequencing Proves Nosocomial Transmission of Fatal Varicella
por: Depledge, Daniel P., et al.
Publicado: (2016)

Mask use among health care workers and feelings of safety at work pre- and post- COVID-19 vaccine
por: O'Donohue, Laura S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a83o81u7aob63hdbjpb8b2imu6